It’s highly unusual to move from a “poison pill” to a $44 billion deal in under two weeks. But Twitter’s board ran out of options.Read More
It’s highly unusual to move from a “poison pill” to a $44 billion deal in under two weeks. But Twitter’s board ran out of options.Read More